Orexigen Obesity Drug Failed By FDA, Possibly Years Before Another
Although obesity is a heavy epidemic in the United States and internationally, the FDA has rejected two weight loss drugs in the second half of 2010 and most recently dealt a heavy blow to Contrave, which was developed by fledgling California company Orexigen. This leaves more than 10 years without a weight control medication on the market and leading scientists back to the drawing board ...

UPDATE 1-FDA denies expanded Avodart OK for now -Glaxo
* Says received complete response letter for new use * Did not specify FDA concerns * Rejection does not affect current Avodart approvals NEW YORK, Jan 26 (Reuters) - U.S. health regulatorsdeclined to ...

FDA plans changes to device approvals
WASHINGTON The Food and Drug Administration is laying out plans to update the 35-year-old system used to approve most medical devices, which has been subject to increasing criticism by public safety advocates.